Advisor Group Inc. Takes Position in Innovator S&P 500 Buffer ETF – January (NYSEARCA:BJAN)

Share on StockTwits

Advisor Group Inc. acquired a new position in shares of Innovator S&P 500 Buffer ETF – January (NYSEARCA:BJAN) during the 1st quarter, HoldingsChannel reports. The firm acquired 43,946 shares of the company’s stock, valued at approximately $1,221,000.

Separately, Cetera Advisors LLC acquired a new position in Innovator S&P 500 Buffer ETF – January during the 1st quarter worth $503,000.

NYSEARCA:BJAN opened at $28.23 on Wednesday. Innovator S&P 500 Buffer ETF – January has a 52-week low of $24.78 and a 52-week high of $28.60.

COPYRIGHT VIOLATION WARNING: “Advisor Group Inc. Takes Position in Innovator S&P 500 Buffer ETF – January (NYSEARCA:BJAN)” was posted by Zolmax and is the property of of Zolmax. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://zolmax.com/investing/advisor-group-inc-takes-position-in-innovator-sp-500-buffer-etf-january-nysearcabjan/3111551.html.

Read More: The Structure of a Futures Contract

Want to see what other hedge funds are holding BJAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator S&P 500 Buffer ETF – January (NYSEARCA:BJAN).

Receive News & Ratings for Innovator S&P 500 Buffer ETF - January Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator S&P 500 Buffer ETF - January and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Expect Bank of Hawaii Co.  to Announce $1.38 Earnings Per Share
Analysts Expect Bank of Hawaii Co. to Announce $1.38 Earnings Per Share
Soarcoin 1-Day Trading Volume Tops $220.00
Soarcoin 1-Day Trading Volume Tops $220.00
Mason Graphite  Shares Up 5.6%
Mason Graphite Shares Up 5.6%
Continental Gold  Shares Up 0.7%
Continental Gold Shares Up 0.7%
Arcus Biosciences Inc  Short Interest Update
Arcus Biosciences Inc Short Interest Update
Hancock Whitney Corp  Given Average Rating of “Buy” by Analysts
Hancock Whitney Corp Given Average Rating of “Buy” by Analysts


 
© 2006-2019 Zolmax.